Results 131 to 140 of about 89,537 (272)

Factors associated with patients in the Scottish Highlands who chose mastectomy when suitable for breast conservation

open access: yes, 2016
Background: Despite being suitable for breast conservation surgery (BCS) a proportion of women choose mastectomy. This study aimed to assess the pre-operative pathological and geographic factors associated with choosing mastectomy rather than BCS in a ...
Abbott, Nick C   +9 more
core   +1 more source

Olaparib‐associated cutaneous vasculitis in a patient with breast cancer

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Marcial Álvarez‐Salafranca   +3 more
wiley   +1 more source

Maximizing Neurovascular Outcomes of Facial Transplantation: A Comprehensive Review

open access: yesClinical Anatomy, Volume 39, Issue 8, Page 965-979, November 2026.
ABSTRACT Facial transplantation is a division of reconstructive surgery which aims to improve the function and appearance of a face that has endured severe disfigurement. Currently, the face transplant procedure uses allogenic tissue, harvested from a brain‐dead donor, to replace damaged facial components.
Olivia A. James, Faye Bennett
wiley   +1 more source

Foot drop in generalized herpes zoster: L5‑predominant polyradiculitis as a rare complication – a case report

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Anna Malfertheiner   +2 more
wiley   +1 more source

Potential Association of BRCA Mutation and Lymphocytic Lobulitis

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Lymphocytic lobulitis (LL) is a rare fibroinflammatory breast lesion historically associated with long‐standing Type 1 diabetes mellitus and autoimmune conditions. Recent evidence suggests possible links between LL and hereditary breast cancer syndromes, particularly BRCA mutations. We present the case of a BRCA1 mutation carrier who developed
Parul Garg   +3 more
wiley   +1 more source

Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy

open access: yesCurrent Oncology
Background: Adjuvant tamoxifen reduces recurrence in patients with ER-positive DCIS treated with lumpectomy and radiation, but its benefit after mastectomy remains unclear.
Netchanok Sae-sim   +2 more
doaj   +1 more source

Defining priorities for care among young adults diagnosed with breast cancer

open access: yesPediatric, Adolescent &Young Adult Cancer, Volume 1, Issue 1, November 2026.
Abstract Introduction Breast cancer is a leading cause of cancer‐related mortality among young adults (YAs) aged 18–39 years. Although the National Comprehensive Cancer Network recommends that YAs be treated at centers with age‐specific expertise, standardized care pathways are lacking.
Caroline Lommer   +9 more
wiley   +1 more source

Thoracic Mobility in Post-Mastectomy Women: An Observational Study

open access: yesRGUHS Journal of Physiotherapy
Background Mastectomy with radiation therapy or chemotherapy leads to retraction of soft tissues and weakness of muscles which can affect the spinal curvature mobility of the spine and ...
Chamrak Ampi   +2 more
doaj   +1 more source

Comparative Immunohistochemical Study of Canine Mammary Tumours: Introducing of Triple‐Negative Profile (ER−/PR−/HER2−) in Benign Mammary Tumours of Animal Model

open access: yesVeterinary Medicine and Science, Volume 12, Issue 6, November 2026.
The study examined 130 dogs that had mastectomies in Tehran, Iran. Malignant tumours were most commonly carcinomas, while the most frequent benign tumours were fibroadenomas. Blood tests indicated that dogs with malignant tumours had lower red blood cell and haemoglobin levels, signifying anaemia and higher monocyte counts compared to those with benign
Hossein Lak, Amir Amniattalab
wiley   +1 more source

CRISPR, APGAR and Cancer Screening: Public Engagement, Controversy and Misaligned Values

open access: yesBioethics, Volume 40, Issue 9, Page 1009-1016, November 2026.
ABSTRACT There are many calls for public engagement in decision‐making around controversial technologies, but far fewer calls for public engagement in deliberation around less controversial interventions. We think the public should be involved in discussing CRISPR, but not in discussing APGAR.
Stephen John
wiley   +1 more source

Home - About - Disclaimer - Privacy